Venus Remedies LimitedNSE: VENUSREM

Press Release Sep 20 2023

· Issued by Venus Remedies Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-20-2023-10

Venus Remedies Limited has informed the Exchange regarding a press release dated September 20, 2023, titled "Venus Remedies extends its oncology portfolio in South Eastern Europe with Serbian marketing approval for gemcitabine and docetaxel.".

View Attachment

6ix hasn’t read this filing yet.

Venus Remedies Limited on 6ix

Earlier from Venus Remedies

Later from Venus Remedies

All Venus Remedies news releases